Enhancing postoperative care by using wrist-wearable devices to predict sepsis
We are excited to announce that Aisthesis Medical will be participating in the upcoming Euroanaesthesia 2024. Our latest study focuses on enhancing postoperative care by using wrist-wearable devices to predict sepsis early, aiming to transform patient outcomes in surgical wards.
Study Overview
Our research employs cutting-edge wrist-wearable devices to continuously monitor vital signs post-abdominal surgery. By integrating this data with patient records, our AI algorithm predicts sepsis onset hours before symptoms appear, significantly outperforming traditional methods like qSOFA.
Impressive Results
Our innovative approach demonstrated a remarkable ability to predict sepsis with 97% accuracy, significantly reducing the risk of late detection which is critical for improving patient survival rates and reducing hospital stays.
Looking Ahead
We believe this technology marks a transformative step in postoperative care, elevating patient safety and enabling proactive health measures.
Join us at Euroanaesthesia 2024 to learn more about how Aisthesis Medical is leading innovations in healthcare technology and improving patient care standards through advanced predictive analytics. We look forward to sharing our insights and discussing the potential impacts of this technology with healthcare professionals from around the world.
We look forward to seeing you there and discussing the future of medical technology.